Innophos Holdings Inc (IPHS.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|57||2017||Chairman of the Board, President, Chief Executive Officer|
|51||2016||Chief Financial Officer, Senior Vice President|
|53||Chief Human Resource Officer, Senior Vice President|
|49||2016||Senior Vice President, Chief Marketing and Technology Officer|
|2017||Senior Vice President - Manufacturing, Engineering and EH&S|
- BRIEF-Innophos Holdings says on July 28, unit entered agreement, plan of merger
- BRIEF-GenNX360 Capital Partners enters agreement to sell Novel Ingredients to Innophos Holdings Inc
- BRIEF-Innophos Holdings Inc Q2 earnings per participating share $0.57
- BRIEF-Innophos to acquire Novel Ingredients to create a nearly $0.5 bln food, health and nutrition platform
- BRIEF-Innophos Holdings Q1 adjusted earnings per share $0.59